Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.
Medpage Today on MSN18h
Some Psoriasis Biologics Better Than Others for Preventing Progression to PsAPsoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback